NCT04107311

Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients

RecruitingOBSERVATIONAL

Trial Details

Start: 2019-09-05Est. Completion: 2027-03-05

Enrollment target: 120 participants

Locations

Contact

Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor

This is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti…

Birmingham, United StatesEst. completion Oct 1, 2029

Small Cell Lung Cancer

Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to …

New Haven, United StatesEst. completion May 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.